DOV vs EBS · P/E 27, rev $7.75B vs rev $1.04B
Dover Corporation (DOV) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Dover Corporation (DOV) is a specialty industrial machinery company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DOV revenue for 2024-12-31 was $7.75B. Net income was $2.70B. Revenue was up 0.8% from 2023-12-31 to 2024-12-31. DOV currently screens at market cap $28.92B and trailing P/E 26.8.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
DOV currently screens at market cap $28.92B and trailing P/E 26.8. EBS currently screens at market cap $416.4M.
Not investment advice. Open the DOV and EBS stock pages for the full models.
Not investment advice.